390
Participants
Start Date
August 1, 2020
Primary Completion Date
August 19, 2021
Study Completion Date
October 5, 2021
Pitavastatin
Pitavastatin, QD
Ezetimibe
Ezetimibe, QD
1PC111
1PC111, QD
Paratus Clinical Research Western Sydney, Blacktown
Northern Beaches Clinical Research, Brookvale
Emeritus Research, Camberwell
Paratus Clinical Research Central Coast, Kanwal
Southern Clinical Trials - Waitemata Ltd., Auckland
Southern Clinical Trials Totara, Auckland
Southern Clinical Trials Group Ltd, Christchurch
Lakeland Clinical Trials Waikato, Hamilton
Southern Clinical Trials Tasman, Nelson
Lakeland Clinical Trials Rotorua, Rotorua
Culloden Research Ltd., Tauranga
Changhua Christian Hospital, Changhua
Chiayi Christian Hospital, Chiayi City
E-Da Hospital, Kaohsiung City
Kaohsiung Chang Gung Memorial Hospital of the C.G.M.F., Kaohsiung City
Kaohsiung Medical University Hospital, Kaohsiung City
Kaohsiung Veterans General Hospital, Kaohsiung City
China Medical University Hospital, Taichung
Chung Shan Medical University Hospital, Taichung
Kuang Tien General Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Chi Mei Medical Center, Tainan City
National Cheng Kung University Hospital, Tainan City
Tainan Municipal Hospital (Managed By Show Chwan Medical Care Corporation), Tainan City
Cathay General Hospital, Taipei
Cheng Hsin General Hospital, Taipei
Far Eastern Memorial Hospital, Taipei
National Taiwan University Hospital, Taipei
Shin Kong Wu Ho-Su Memorial Hospital, Taipei
Taipei Medical University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Tamsui Mackay Memorial Hospital, Taipei
Tri-Service General Hospital, Taipei
Chang Gung Medical Foundation- LinKuo Branch, Taoyuan District
Orient Pharma Co., Ltd.
INDUSTRY